Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy
Abstract Background/Aims: the pathogenesis of sepsis-associated encephalopathy (SAE) is multifactorial, involving neurotransmitter alterations, inflammatory cytokines, oxidative damage, mitochondrial dysfunction, apoptosis, and other factors. Mitochondria are major producers of reactive oxygen speci...
Gespeichert in:
Veröffentlicht in: | Cellular Physiology and Biochemistry 2018-10, Vol.49 (6), p.2163-2173 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2173 |
---|---|
container_issue | 6 |
container_start_page | 2163 |
container_title | Cellular Physiology and Biochemistry |
container_volume | 49 |
creator | Wang, Pengfei Hu, Yueyu Yao, Danhua Li, Yousheng |
description | Abstract
Background/Aims: the pathogenesis of sepsis-associated encephalopathy (SAE) is multifactorial, involving neurotransmitter alterations, inflammatory cytokines, oxidative damage, mitochondrial dysfunction, apoptosis, and other factors. Mitochondria are major producers of reactive oxygen species, resulting in cellular injury. Omi/HtrA2 is a proapoptotic mitochondrial serine protease involved in caspase-dependent cell death; it is translocated from mitochondria to the cytosol after an apoptotic insult. We previously found that UCF-101, a specific inhibitor of Omi/HtrA2, has neuroprotective effects on cerebral oxidative injury and cognitive impairment in septic rats. In this study, the mechanisms and molecular pathways underlying these effects were investigated. Methods: Male Sprague–Dawley rats were subjected to cecal ligation and puncture (CLP) or sham-operated laparotomy and were administered vehicle or UCF-101 (10 µmol/kg). The hippocampus was isolated for subsequent analysis. Omi/HtrA2 expression in the mitochondria or cytosol was evaluated by immunofluorescence or western blotting. Terminal deoxynucleotidyl transferase dUTP nick end labeling staining was utilized to evaluate levels of apoptosis, and western blotting was used to evaluate apoptosis-related proteins, such as cleaved caspase-3, caspase-9, and poly (ADP-ribose) polymerase (PARP). Tight junction expression was assessed by immunofluorescence and western blotting. Mitochondrial function, inflammatory cytokines, and oxidative stress were also assayed. In addition, a wet/dry method was used to evaluate brain edema and Evans blue extravasation was used to evaluate blood–brain barrier (BBB) integrity. Results: After CLP treatment, the hippocampus exhibited a mild increase in Omi/HtrA2 expression; cytosolic Omi/HtrA2 expression increased significantly, whereas mitochondrial Omi/HtrA2 expression was reduced, indicating that CLP-induced oxidative stress resulted in the translocation of Omi/HtrA2 from mitochondria to the cytosol. Hippocampal cleaved caspase-3, caspase-9, and PARP levels were significantly higher in animals treated with CLP than in sham-operated animals, while XIAP expression was lower. Treatment with UCF-101 prevented the mobilization of Omi/HtrA2 from mitochondria to the cytosol, attenuated XIAP degradation, and decreased cleaved caspase-3, caspase-9, and PARP expression as well as apoptosis. UCF-101 also reversed the decreased mitochondrial complex I, II, and III respiration a |
doi_str_mv | 10.1159/000493819 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2301884654</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A637531223</galeid><doaj_id>oai_doaj_org_article_5933e7b08bdb4ee798e5ef15c2f09631</doaj_id><sourcerecordid>A637531223</sourcerecordid><originalsourceid>FETCH-LOGICAL-c530t-235bc1f7ad685bbcd72f5c66ecd2498fdd05423f3dc6d53f83873589bb071add3</originalsourceid><addsrcrecordid>eNptkUtv1DAUhSMEog9YsEcoEhtYpPUjfi2HodBKrVrxWFuOfT3jIRMHJxGaf18PGQYJIS9sX3333HN1iuIVRhcYM3WJEKoVlVg9KU5xTXClhJBP8xthVkklxUlxNgwblL9CkefFCUVE8pqL0yLcb8Pl9ZgWpPwCq6k1IwylKe_CGO06di4FU32EHjoH3Vgu-tiPcQy2fDDj-pfZlaHb01MKHZR30UFbRl9-hX7PXHUW-rVpY5_h3YvimTftAC8P93nx_dPVt-V1dXv_-Wa5uK0so2isCGWNxV4YxyVrGusE8cxyDtaRWknvHGI1oZ46yx2jXlIpKJOqaZDAxjl6XtzMui6aje5T2Jq009EE_bsQ00qblO21oJmiFESDZOOaGkAoCQw8ZpZ4pDjFWevdrNWn-HOCYdTbMFhoW9NBnAZNMOayVlipjL79B93EKXV5U00owlLWnNWZupiplcnzQ-fjmIzNx8E22NiBD7m-4FQwigmhueH93GBTHIYE_rgRRnofvj6Gn9k3BwtTswV3JP-k_dfjD5NWkI7A8uHDLKF75zP1-r_UYcojAze8zg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2301884654</pqid></control><display><type>article</type><title>Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Karger Open Access</source><creator>Wang, Pengfei ; Hu, Yueyu ; Yao, Danhua ; Li, Yousheng</creator><creatorcontrib>Wang, Pengfei ; Hu, Yueyu ; Yao, Danhua ; Li, Yousheng</creatorcontrib><description>Abstract
Background/Aims: the pathogenesis of sepsis-associated encephalopathy (SAE) is multifactorial, involving neurotransmitter alterations, inflammatory cytokines, oxidative damage, mitochondrial dysfunction, apoptosis, and other factors. Mitochondria are major producers of reactive oxygen species, resulting in cellular injury. Omi/HtrA2 is a proapoptotic mitochondrial serine protease involved in caspase-dependent cell death; it is translocated from mitochondria to the cytosol after an apoptotic insult. We previously found that UCF-101, a specific inhibitor of Omi/HtrA2, has neuroprotective effects on cerebral oxidative injury and cognitive impairment in septic rats. In this study, the mechanisms and molecular pathways underlying these effects were investigated. Methods: Male Sprague–Dawley rats were subjected to cecal ligation and puncture (CLP) or sham-operated laparotomy and were administered vehicle or UCF-101 (10 µmol/kg). The hippocampus was isolated for subsequent analysis. Omi/HtrA2 expression in the mitochondria or cytosol was evaluated by immunofluorescence or western blotting. Terminal deoxynucleotidyl transferase dUTP nick end labeling staining was utilized to evaluate levels of apoptosis, and western blotting was used to evaluate apoptosis-related proteins, such as cleaved caspase-3, caspase-9, and poly (ADP-ribose) polymerase (PARP). Tight junction expression was assessed by immunofluorescence and western blotting. Mitochondrial function, inflammatory cytokines, and oxidative stress were also assayed. In addition, a wet/dry method was used to evaluate brain edema and Evans blue extravasation was used to evaluate blood–brain barrier (BBB) integrity. Results: After CLP treatment, the hippocampus exhibited a mild increase in Omi/HtrA2 expression; cytosolic Omi/HtrA2 expression increased significantly, whereas mitochondrial Omi/HtrA2 expression was reduced, indicating that CLP-induced oxidative stress resulted in the translocation of Omi/HtrA2 from mitochondria to the cytosol. Hippocampal cleaved caspase-3, caspase-9, and PARP levels were significantly higher in animals treated with CLP than in sham-operated animals, while XIAP expression was lower. Treatment with UCF-101 prevented the mobilization of Omi/HtrA2 from mitochondria to the cytosol, attenuated XIAP degradation, and decreased cleaved caspase-3, caspase-9, and PARP expression as well as apoptosis. UCF-101 also reversed the decreased mitochondrial complex I, II, and III respiration and the reduced ATP caused by CLP. In addition, UCF-101 treatment resulted in a significant improvement in BBB integrity, as demonstrated by increased occludin, claudin-5, and zonula occludens 1 levels and reduced Evans blue extravasation. No significant effects of UCF-101 on brain edema were found. Inflammatory cytokines and oxidative stress were significantly higher in the CLP-treated group than in the sham-operated group. However, the inhibition of Omi/HtrA2 by UCF-101 significantly alleviated these responses. Conclusion: Our data indicated that Omi/ HtrA2 regulates a mitochondria-dependent apoptotic pathway in a murine model of septic encephalopathy. Inhibition of Omi/HtrA2 by UCF-101 leads to neuroprotection by inhibiting the cytosolic translocation of Omi/HtrA2 and antagonizing the caspase-dependent apoptosis pathway. Therapeutic interventions that inhibit Omi/HtrA2 translocation or protease activity may provide a novel method to treat SAE.</description><identifier>ISSN: 1015-8987</identifier><identifier>EISSN: 1421-9778</identifier><identifier>DOI: 10.1159/000493819</identifier><identifier>PMID: 30286467</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Abdomen ; Animal cognition ; Animals ; Apoptosis ; Apoptosis - drug effects ; Brain ; Caspase 3 - metabolism ; CLP ; Cognitive ability ; Complications and side effects ; Cytokines ; Cytosol - metabolism ; Development and progression ; Disease Models, Animal ; Dynamins - genetics ; Dynamins - metabolism ; Edema ; Electron Transport Chain Complex Proteins - metabolism ; Encephalopathy ; Health aspects ; High-Temperature Requirement A Serine Peptidase 2 - antagonists & inhibitors ; High-Temperature Requirement A Serine Peptidase 2 - genetics ; High-Temperature Requirement A Serine Peptidase 2 - metabolism ; Hippocampus - drug effects ; Hippocampus - metabolism ; Immunoglobulins ; Laboratory animals ; Male ; Malondialdehyde - metabolism ; Membrane Proteins - metabolism ; Metabolism ; Mitochondria ; Mitochondria - drug effects ; Mitochondria - metabolism ; Mitochondrial Proteins - metabolism ; Occludin - metabolism ; Omi/HtrA2 ; Original Paper ; Oxidative stress ; Pathogenesis ; Physiological aspects ; Poly(ADP-ribose) Polymerases - metabolism ; Proteases ; Pyrimidinones - pharmacology ; Rats ; Rats, Sprague-Dawley ; Reactive oxygen species ; Risk factors ; Rodents ; Sepsis ; Sepsis - pathology ; Sepsis-associated encephalopathy ; Thiones - pharmacology ; UCF-101 ; X-Linked Inhibitor of Apoptosis Protein - metabolism</subject><ispartof>Cellular Physiology and Biochemistry, 2018-10, Vol.49 (6), p.2163-2173</ispartof><rights>2018 The Author(s). Published by S. Karger AG, Basel</rights><rights>2018 The Author(s). Published by S. Karger AG, Basel.</rights><rights>COPYRIGHT 2018 S. Karger AG</rights><rights>2018 The Author(s). Published by S. Karger AG, Basel . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c530t-235bc1f7ad685bbcd72f5c66ecd2498fdd05423f3dc6d53f83873589bb071add3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,2096,27614,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30286467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Pengfei</creatorcontrib><creatorcontrib>Hu, Yueyu</creatorcontrib><creatorcontrib>Yao, Danhua</creatorcontrib><creatorcontrib>Li, Yousheng</creatorcontrib><title>Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy</title><title>Cellular Physiology and Biochemistry</title><addtitle>Cell Physiol Biochem</addtitle><description>Abstract
Background/Aims: the pathogenesis of sepsis-associated encephalopathy (SAE) is multifactorial, involving neurotransmitter alterations, inflammatory cytokines, oxidative damage, mitochondrial dysfunction, apoptosis, and other factors. Mitochondria are major producers of reactive oxygen species, resulting in cellular injury. Omi/HtrA2 is a proapoptotic mitochondrial serine protease involved in caspase-dependent cell death; it is translocated from mitochondria to the cytosol after an apoptotic insult. We previously found that UCF-101, a specific inhibitor of Omi/HtrA2, has neuroprotective effects on cerebral oxidative injury and cognitive impairment in septic rats. In this study, the mechanisms and molecular pathways underlying these effects were investigated. Methods: Male Sprague–Dawley rats were subjected to cecal ligation and puncture (CLP) or sham-operated laparotomy and were administered vehicle or UCF-101 (10 µmol/kg). The hippocampus was isolated for subsequent analysis. Omi/HtrA2 expression in the mitochondria or cytosol was evaluated by immunofluorescence or western blotting. Terminal deoxynucleotidyl transferase dUTP nick end labeling staining was utilized to evaluate levels of apoptosis, and western blotting was used to evaluate apoptosis-related proteins, such as cleaved caspase-3, caspase-9, and poly (ADP-ribose) polymerase (PARP). Tight junction expression was assessed by immunofluorescence and western blotting. Mitochondrial function, inflammatory cytokines, and oxidative stress were also assayed. In addition, a wet/dry method was used to evaluate brain edema and Evans blue extravasation was used to evaluate blood–brain barrier (BBB) integrity. Results: After CLP treatment, the hippocampus exhibited a mild increase in Omi/HtrA2 expression; cytosolic Omi/HtrA2 expression increased significantly, whereas mitochondrial Omi/HtrA2 expression was reduced, indicating that CLP-induced oxidative stress resulted in the translocation of Omi/HtrA2 from mitochondria to the cytosol. Hippocampal cleaved caspase-3, caspase-9, and PARP levels were significantly higher in animals treated with CLP than in sham-operated animals, while XIAP expression was lower. Treatment with UCF-101 prevented the mobilization of Omi/HtrA2 from mitochondria to the cytosol, attenuated XIAP degradation, and decreased cleaved caspase-3, caspase-9, and PARP expression as well as apoptosis. UCF-101 also reversed the decreased mitochondrial complex I, II, and III respiration and the reduced ATP caused by CLP. In addition, UCF-101 treatment resulted in a significant improvement in BBB integrity, as demonstrated by increased occludin, claudin-5, and zonula occludens 1 levels and reduced Evans blue extravasation. No significant effects of UCF-101 on brain edema were found. Inflammatory cytokines and oxidative stress were significantly higher in the CLP-treated group than in the sham-operated group. However, the inhibition of Omi/HtrA2 by UCF-101 significantly alleviated these responses. Conclusion: Our data indicated that Omi/ HtrA2 regulates a mitochondria-dependent apoptotic pathway in a murine model of septic encephalopathy. Inhibition of Omi/HtrA2 by UCF-101 leads to neuroprotection by inhibiting the cytosolic translocation of Omi/HtrA2 and antagonizing the caspase-dependent apoptosis pathway. Therapeutic interventions that inhibit Omi/HtrA2 translocation or protease activity may provide a novel method to treat SAE.</description><subject>Abdomen</subject><subject>Animal cognition</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Brain</subject><subject>Caspase 3 - metabolism</subject><subject>CLP</subject><subject>Cognitive ability</subject><subject>Complications and side effects</subject><subject>Cytokines</subject><subject>Cytosol - metabolism</subject><subject>Development and progression</subject><subject>Disease Models, Animal</subject><subject>Dynamins - genetics</subject><subject>Dynamins - metabolism</subject><subject>Edema</subject><subject>Electron Transport Chain Complex Proteins - metabolism</subject><subject>Encephalopathy</subject><subject>Health aspects</subject><subject>High-Temperature Requirement A Serine Peptidase 2 - antagonists & inhibitors</subject><subject>High-Temperature Requirement A Serine Peptidase 2 - genetics</subject><subject>High-Temperature Requirement A Serine Peptidase 2 - metabolism</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Immunoglobulins</subject><subject>Laboratory animals</subject><subject>Male</subject><subject>Malondialdehyde - metabolism</subject><subject>Membrane Proteins - metabolism</subject><subject>Metabolism</subject><subject>Mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondrial Proteins - metabolism</subject><subject>Occludin - metabolism</subject><subject>Omi/HtrA2</subject><subject>Original Paper</subject><subject>Oxidative stress</subject><subject>Pathogenesis</subject><subject>Physiological aspects</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Proteases</subject><subject>Pyrimidinones - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reactive oxygen species</subject><subject>Risk factors</subject><subject>Rodents</subject><subject>Sepsis</subject><subject>Sepsis - pathology</subject><subject>Sepsis-associated encephalopathy</subject><subject>Thiones - pharmacology</subject><subject>UCF-101</subject><subject>X-Linked Inhibitor of Apoptosis Protein - metabolism</subject><issn>1015-8987</issn><issn>1421-9778</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptkUtv1DAUhSMEog9YsEcoEhtYpPUjfi2HodBKrVrxWFuOfT3jIRMHJxGaf18PGQYJIS9sX3333HN1iuIVRhcYM3WJEKoVlVg9KU5xTXClhJBP8xthVkklxUlxNgwblL9CkefFCUVE8pqL0yLcb8Pl9ZgWpPwCq6k1IwylKe_CGO06di4FU32EHjoH3Vgu-tiPcQy2fDDj-pfZlaHb01MKHZR30UFbRl9-hX7PXHUW-rVpY5_h3YvimTftAC8P93nx_dPVt-V1dXv_-Wa5uK0so2isCGWNxV4YxyVrGusE8cxyDtaRWknvHGI1oZ46yx2jXlIpKJOqaZDAxjl6XtzMui6aje5T2Jq009EE_bsQ00qblO21oJmiFESDZOOaGkAoCQw8ZpZ4pDjFWevdrNWn-HOCYdTbMFhoW9NBnAZNMOayVlipjL79B93EKXV5U00owlLWnNWZupiplcnzQ-fjmIzNx8E22NiBD7m-4FQwigmhueH93GBTHIYE_rgRRnofvj6Gn9k3BwtTswV3JP-k_dfjD5NWkI7A8uHDLKF75zP1-r_UYcojAze8zg</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Wang, Pengfei</creator><creator>Hu, Yueyu</creator><creator>Yao, Danhua</creator><creator>Li, Yousheng</creator><general>S. Karger AG</general><general>Cell Physiol Biochem Press GmbH & Co KG</general><scope>M--</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20181001</creationdate><title>Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy</title><author>Wang, Pengfei ; Hu, Yueyu ; Yao, Danhua ; Li, Yousheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c530t-235bc1f7ad685bbcd72f5c66ecd2498fdd05423f3dc6d53f83873589bb071add3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abdomen</topic><topic>Animal cognition</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Brain</topic><topic>Caspase 3 - metabolism</topic><topic>CLP</topic><topic>Cognitive ability</topic><topic>Complications and side effects</topic><topic>Cytokines</topic><topic>Cytosol - metabolism</topic><topic>Development and progression</topic><topic>Disease Models, Animal</topic><topic>Dynamins - genetics</topic><topic>Dynamins - metabolism</topic><topic>Edema</topic><topic>Electron Transport Chain Complex Proteins - metabolism</topic><topic>Encephalopathy</topic><topic>Health aspects</topic><topic>High-Temperature Requirement A Serine Peptidase 2 - antagonists & inhibitors</topic><topic>High-Temperature Requirement A Serine Peptidase 2 - genetics</topic><topic>High-Temperature Requirement A Serine Peptidase 2 - metabolism</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Immunoglobulins</topic><topic>Laboratory animals</topic><topic>Male</topic><topic>Malondialdehyde - metabolism</topic><topic>Membrane Proteins - metabolism</topic><topic>Metabolism</topic><topic>Mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondrial Proteins - metabolism</topic><topic>Occludin - metabolism</topic><topic>Omi/HtrA2</topic><topic>Original Paper</topic><topic>Oxidative stress</topic><topic>Pathogenesis</topic><topic>Physiological aspects</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Proteases</topic><topic>Pyrimidinones - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reactive oxygen species</topic><topic>Risk factors</topic><topic>Rodents</topic><topic>Sepsis</topic><topic>Sepsis - pathology</topic><topic>Sepsis-associated encephalopathy</topic><topic>Thiones - pharmacology</topic><topic>UCF-101</topic><topic>X-Linked Inhibitor of Apoptosis Protein - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Pengfei</creatorcontrib><creatorcontrib>Hu, Yueyu</creatorcontrib><creatorcontrib>Yao, Danhua</creatorcontrib><creatorcontrib>Li, Yousheng</creatorcontrib><collection>Karger Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cellular Physiology and Biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Pengfei</au><au>Hu, Yueyu</au><au>Yao, Danhua</au><au>Li, Yousheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy</atitle><jtitle>Cellular Physiology and Biochemistry</jtitle><addtitle>Cell Physiol Biochem</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>49</volume><issue>6</issue><spage>2163</spage><epage>2173</epage><pages>2163-2173</pages><issn>1015-8987</issn><eissn>1421-9778</eissn><abstract>Abstract
Background/Aims: the pathogenesis of sepsis-associated encephalopathy (SAE) is multifactorial, involving neurotransmitter alterations, inflammatory cytokines, oxidative damage, mitochondrial dysfunction, apoptosis, and other factors. Mitochondria are major producers of reactive oxygen species, resulting in cellular injury. Omi/HtrA2 is a proapoptotic mitochondrial serine protease involved in caspase-dependent cell death; it is translocated from mitochondria to the cytosol after an apoptotic insult. We previously found that UCF-101, a specific inhibitor of Omi/HtrA2, has neuroprotective effects on cerebral oxidative injury and cognitive impairment in septic rats. In this study, the mechanisms and molecular pathways underlying these effects were investigated. Methods: Male Sprague–Dawley rats were subjected to cecal ligation and puncture (CLP) or sham-operated laparotomy and were administered vehicle or UCF-101 (10 µmol/kg). The hippocampus was isolated for subsequent analysis. Omi/HtrA2 expression in the mitochondria or cytosol was evaluated by immunofluorescence or western blotting. Terminal deoxynucleotidyl transferase dUTP nick end labeling staining was utilized to evaluate levels of apoptosis, and western blotting was used to evaluate apoptosis-related proteins, such as cleaved caspase-3, caspase-9, and poly (ADP-ribose) polymerase (PARP). Tight junction expression was assessed by immunofluorescence and western blotting. Mitochondrial function, inflammatory cytokines, and oxidative stress were also assayed. In addition, a wet/dry method was used to evaluate brain edema and Evans blue extravasation was used to evaluate blood–brain barrier (BBB) integrity. Results: After CLP treatment, the hippocampus exhibited a mild increase in Omi/HtrA2 expression; cytosolic Omi/HtrA2 expression increased significantly, whereas mitochondrial Omi/HtrA2 expression was reduced, indicating that CLP-induced oxidative stress resulted in the translocation of Omi/HtrA2 from mitochondria to the cytosol. Hippocampal cleaved caspase-3, caspase-9, and PARP levels were significantly higher in animals treated with CLP than in sham-operated animals, while XIAP expression was lower. Treatment with UCF-101 prevented the mobilization of Omi/HtrA2 from mitochondria to the cytosol, attenuated XIAP degradation, and decreased cleaved caspase-3, caspase-9, and PARP expression as well as apoptosis. UCF-101 also reversed the decreased mitochondrial complex I, II, and III respiration and the reduced ATP caused by CLP. In addition, UCF-101 treatment resulted in a significant improvement in BBB integrity, as demonstrated by increased occludin, claudin-5, and zonula occludens 1 levels and reduced Evans blue extravasation. No significant effects of UCF-101 on brain edema were found. Inflammatory cytokines and oxidative stress were significantly higher in the CLP-treated group than in the sham-operated group. However, the inhibition of Omi/HtrA2 by UCF-101 significantly alleviated these responses. Conclusion: Our data indicated that Omi/ HtrA2 regulates a mitochondria-dependent apoptotic pathway in a murine model of septic encephalopathy. Inhibition of Omi/HtrA2 by UCF-101 leads to neuroprotection by inhibiting the cytosolic translocation of Omi/HtrA2 and antagonizing the caspase-dependent apoptosis pathway. Therapeutic interventions that inhibit Omi/HtrA2 translocation or protease activity may provide a novel method to treat SAE.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>30286467</pmid><doi>10.1159/000493819</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1015-8987 |
ispartof | Cellular Physiology and Biochemistry, 2018-10, Vol.49 (6), p.2163-2173 |
issn | 1015-8987 1421-9778 |
language | eng |
recordid | cdi_proquest_journals_2301884654 |
source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; Karger Open Access |
subjects | Abdomen Animal cognition Animals Apoptosis Apoptosis - drug effects Brain Caspase 3 - metabolism CLP Cognitive ability Complications and side effects Cytokines Cytosol - metabolism Development and progression Disease Models, Animal Dynamins - genetics Dynamins - metabolism Edema Electron Transport Chain Complex Proteins - metabolism Encephalopathy Health aspects High-Temperature Requirement A Serine Peptidase 2 - antagonists & inhibitors High-Temperature Requirement A Serine Peptidase 2 - genetics High-Temperature Requirement A Serine Peptidase 2 - metabolism Hippocampus - drug effects Hippocampus - metabolism Immunoglobulins Laboratory animals Male Malondialdehyde - metabolism Membrane Proteins - metabolism Metabolism Mitochondria Mitochondria - drug effects Mitochondria - metabolism Mitochondrial Proteins - metabolism Occludin - metabolism Omi/HtrA2 Original Paper Oxidative stress Pathogenesis Physiological aspects Poly(ADP-ribose) Polymerases - metabolism Proteases Pyrimidinones - pharmacology Rats Rats, Sprague-Dawley Reactive oxygen species Risk factors Rodents Sepsis Sepsis - pathology Sepsis-associated encephalopathy Thiones - pharmacology UCF-101 X-Linked Inhibitor of Apoptosis Protein - metabolism |
title | Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A40%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Omi/HtrA2%20Regulates%20a%20Mitochondria-Dependent%20Apoptotic%20Pathway%20in%20a%20Murine%20Model%20of%20Septic%20Encephalopathy&rft.jtitle=Cellular%20Physiology%20and%20Biochemistry&rft.au=Wang,%20Pengfei&rft.date=2018-10-01&rft.volume=49&rft.issue=6&rft.spage=2163&rft.epage=2173&rft.pages=2163-2173&rft.issn=1015-8987&rft.eissn=1421-9778&rft_id=info:doi/10.1159/000493819&rft_dat=%3Cgale_proqu%3EA637531223%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2301884654&rft_id=info:pmid/30286467&rft_galeid=A637531223&rft_doaj_id=oai_doaj_org_article_5933e7b08bdb4ee798e5ef15c2f09631&rfr_iscdi=true |